| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $174.9M | -26.2% |
| Cost of Revenue | $114.5M | -38.8% |
| R&D Expense | $29.4M | +2.0% |
| SG&A Expense | $54.3M | +21.5% |
| Operating Income | -$41.8M | +3.2% |
| Pre-tax Income | -$33.4M | +3.8% |
| Income Tax | $267K | +347.2% |
| Net Income | -$33.6M | +2.7% |
| EPS (Basic) | -$0.17 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $142.5M | -33.8% |
| Accounts Receivable | $59.3M | -4.2% |
| Inventory | $35.3M | -15.2% |
| Current Assets | $257.6M | -24.3% |
| Total Assets | $420.2M | -17.6% |
| Current Liabilities | $71.0M | -39.4% |
| Total Liabilities | $130.7M | -21.9% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$32.9M | -650.3% |
| Capital Expenditures | $1.8M | +1102.0% |
| Investing Cash Flow | -$7.6M | -26.2% |
| Financing Cash Flow | -$33.0M | -1630.3% |
| Free Cash Flow | -$34.7M | -694.4% |
| +0.0% |
| EPS (Diluted) | -$0.17 | +0.0% |
| Stockholders' Equity |
| $289.4M |
| -15.5% |